Conference Description
A Point-Counterpoint Debate on the Latest Practice and Therapeutic Trends in Rheumatology
This program is open only to Rheumatologists and nurse practitioners and physician assistants working in Rheumatology practices.
September 20, 2007
Morton's Steakhouse
5050 Town Center Circle
Boca Raton, Florida
Tell a friend about this conference
Download the brochure for this conference
CME Credits 2.0*
Nonrefundable registration fee: $0.
Target Audience: This conference is for Rheumatologists, rheumatology nurse practitioners, physician assistants, and practice administrators working in rheumatology practices.
Program Summary:
Should We or Shouldn’t We? A Point-Counterpoint Debate on the Latest Practice and
Therapeutic Trends in Rheumatology, is a highly interactive, 2-hour, live point-counterpoint,
debate-style symposium. This CME activity will challenge clinicians and health care
professionals treating rheumatic diseases to determine where they lie on the spectrum of
practice management and disease management and to evaluate if they are providing
services and treating patients to maximize outcomes.
This two-part program will increase awareness of important issues related to new diagnostic
and treatment options and issues affecting the management of today’s rheumatology
practice. In Part I, Current Issues in the Treatment of Rheumatic Diseases, speakers will
discuss issues in the diagnosis and management of rheumatic diseases. In Part II, Current
Issues in Rheumatology Practice Management, speakers will discuss issues in the
management of the rheumatology practice. The goal of each part of this program is to
provide improved health care services to patients and to improve patient outcomes.
Learning Objectives:
At the conclusion of this program, attendees will be able to:
- Describe the potential benefits of early diagnosis and aggressive treatment in patients
with RA
- Discuss the benefits (or lack thereof) of utilization of MRI as a diagnostic tool
- Describe the available disease activity assessment tools and discuss the ramifications
for a daily clinical practice
- Discuss the issues regarding the appropriate time and indications to switch/adjust
biologic therapy in RA
- Discuss the evolution of infusion therapy sites as a referral source and clinical
research model
Agenda:
| 6:30-7:00 pm |
|
Welcome and Registration |
| 7:00-8:00 pm |
|
Current Issues in the Treatment of
Rheumatic Diseases |
| 8:00-9:00 pm |
|
Current Issues in Rheumatology
Practice Management |
Faculty:
Norman B. Gaylis, MD
Clinical Associate Professor
University of Miami School of Medicine
President and Managing Partner, Arthritis and Rheumatic Disease Specialties
Aventura, Florida
Marc Cohen, MD
Professor of Medicine, Mayo Medical School
Chairman of Division of Rheumatology, Mayo Clinic
Jacksonville, Florida
*Continuing Education Information
This activity has been planned and implemented in accordance with the Essentials
and Standards of the Accreditation Council for Continuing Medical Education
(ACCME) through the joint sponsorship of the University of Massachusetts Medical
School (UMMS) and the National Association for Continuing Education. The
University of Massachusetts Medical School is accredited by the Accreditation
Council for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians. The University of Massachusetts Medical School designates
this educational activity for a maximum of 2 AMA PRA Category I Credit(s)TM.
Physicians should only claim credit commensurate with the extent of their participation
in the activity.
Under the auspices of the University of Massachusetts Medical School Office of
Continuing Education this offering meets the requirements for 2 contact hours, as
specified by the Massachusetts Board of Registration in Nursing (244- CMR 5.04).
Each nurse should claim only those hours of credit that he/she actually spent in the
educational activity.
Policy on Faculty and Provider Disclosure: It is the policy of the University of
Massachusetts Medical School to ensure fair balance, independence, objectivity and
scientific rigor in all activities. All faculty participating in CME activities sponsored
by the University of Massachusetts Medical School are required to present evidencedbased
data, identify and reference off-label product use and disclose all relevant
financial relationships with those supporting the activity or others whose products or
services are discussed. Faculty disclosure will be provided in the activity materials.
This program was supported by an educational grant from Genentech and Biogen Idec.
|
